Elanco Animal Health Inc ELAN

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $24.42
Market Cap $12.20B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑6.2% YoY
$4.71B
3-Yr CAGR: 2.2%
Net Income
N/A
Net Margin: N/A
Free Cash Flow ↓-27.9% YoY
$284.00M
FCF Yield: 2.33%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: N/A

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ELAN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $2,889.0M $1,395.1M $173.8M $75.2M
FY 2018 $3,066.8M +6.2% $1,493.0M 0.00% $487.3M $352.8M +369.1%
FY 2019 $3,071.0M +0.1% $1,600.7M 0.00% $224.1M $83.7M -76.3%
FY 2020 $3,273.3M +6.6% $1,606.7M 0.00% $-41.0M $-175.6M -309.8%
FY 2021 $4,765.0M +45.6% $2,631.0M 0.00% $483.0M $357.0M +303.3%
FY 2022 $4,411.0M -7.4% $2,498.0M 0.00% $452.0M $315.0M -11.8%
FY 2023 $4,417.0M +0.1% $2,486.0M 0.00% $271.0M $131.0M -58.4%
FY 2024 $4,439.0M +0.5% $2,436.0M 0.00% $541.0M $394.0M +200.8%
FY 2025 $4,715.0M +6.2% $2,593.0M 0.00% $560.0M $284.0M -27.9%
$

Valuation

Market Price $24.42
Market Cap $12.20B
Enterprise Value $15.59B
P/E Ratio N/A
P/B Ratio 1.86
FCF Yield 2.33%
Dividend Yield N/A
Shares Outstanding 499,449,600
%

Profitability & Margins

Gross Margin 54.99%
Operating Margin N/A
Net Margin N/A
Return on Equity (ROE) N/A
Return on Assets (ROA) N/A
Asset Turnover 0.35x
Revenue 3-Yr CAGR 2.25%
🛡️

Financial Health & Liquidity

Current Ratio 6.49
Cash Ratio 1.02
Debt / Equity 0.602
Debt / Assets 0.295
Cash & Equivalents $545.00M
Total Debt $3.94B
Book Value / Share $13.11
💧

Cash Flow Efficiency

Operating Cash Flow $560.00M
Capital Expenditures (CapEx) $276.00M
Free Cash Flow $284.00M
OCF / Revenue 11.88%
FCF / Revenue 6.02%
FCF 3-Yr CAGR -3.39%
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $13.11
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $13.36B
Total Liabilities $6.81B
Stockholders' Equity $6.55B
Current Assets $3.46B
Current Liabilities $533.00M